Genesis Healthcare Announces GeneLock™, the World's First Genomic Data Protection Platform
Genesis Healthcare launched 'GeneLock™', a revolutionary biosecurity platform for genomic data. It protects sensitive genetic information through data fragmentation, decentralization, and strict reconstruction control.
📋 Article Processing Timeline
- 📰 Published: April 25, 2026 at 03:30
- 🔍 Collected: April 24, 2026 at 19:02
- 🤖 AI Analyzed: April 24, 2026 at 20:36 (1h 34m after Collected)
Tokyo — April 24, 2026 — Genesis Healthcare Co., Ltd. announced today GeneLock™, a new genomic security platform for protecting and managing genomic data, one of the world's most highly sensitive assets.
Genomic data is rapidly becoming critical infrastructure. Its protection requires more than just encryption; a new protection model is needed. GeneLock introduces a new approach to genomic data protection by combining data fragmentation, decentralized protection, and reconstruction control as the world's first genetic data protection platform. By fragmenting and decentralizing genomic information into independent, secure environments, it prevents significant exposure and allows reconstruction only under strict conditions.
To Protect the World's Most Personal Data
Genomic data is becoming a strategic asset, but many existing systems were not designed with its protection in mind. Designed with data sovereignty as a premise, GeneLock adopts an architecture based on the following philosophies to protect genomic assets related to humans, animals, plants, and pathogens:
- Fragmentation for protection
- Decentralization for resilience
- Reconstruction only under strict conditions
- Governance based on data sovereignty
- Scalability for diverse genomic assets
A New Category: Biosecurity for Genomic Data
Genomic information introduces new kinds of risks. GeneLock treats DNA as a strategic biological asset requiring specialized protection, aiming to establish a new category of 'biosecurity for genomic data'.
Michel Mommejat, Representative Director of Genesis Healthcare, stated: 'Genomic data is becoming the foundational infrastructure that supports healthcare, research, and the expanding bioeconomy. Through GeneLock, we aim to pioneer a new category of biosecurity for genomic assets.'
GeneLock is designed for broad use, ranging from government-led genomic programs, large-scale databases, research institutions, and life science companies, to consumer applications including select GeneLife test kits, extending advanced genetic data protection from the institutional level to the individual level. GeneLock embodies Genesis Healthcare's vision for a trusted platform for next-generation genomic biosecurity.
For more details, please visit: www.adam-innovations.com
Media Contact:
Email: press@adam-innnovations.com
About Genesis Healthcare Co., Ltd.:
Genesis Healthcare Co., Ltd. (English company name: A.D.A.M. Innovations Co.) is a pioneer in genomics, AI, and precision health solutions. It develops cutting-edge technologies across various genetic fields, including clinical diagnostics, AI-driven R&D data platforms, and consumer genetic testing services. To date, it has conducted over 2.9 million genetic tests and holds one of the largest R&D genomic databases of the Japanese population.
About GeneLock™
GeneLock™ is a secure, sovereign infrastructure for large-scale genomic data. Through encryption, fragmentation, and decentralized architecture, it enables controlled access, robust protection, and governed utilization of high-value datasets in clinical, research, and consumer domains. Designed with data sovereignty in mind, it supports deployment in on-premises and hybrid cloud environments.
GeneLock (trademark pending), GeneLife, and DNA DAY are registered trademarks of Genesis Healthcare Co., Ltd.
Genomic data is rapidly becoming critical infrastructure. Its protection requires more than just encryption; a new protection model is needed. GeneLock introduces a new approach to genomic data protection by combining data fragmentation, decentralized protection, and reconstruction control as the world's first genetic data protection platform. By fragmenting and decentralizing genomic information into independent, secure environments, it prevents significant exposure and allows reconstruction only under strict conditions.
To Protect the World's Most Personal Data
Genomic data is becoming a strategic asset, but many existing systems were not designed with its protection in mind. Designed with data sovereignty as a premise, GeneLock adopts an architecture based on the following philosophies to protect genomic assets related to humans, animals, plants, and pathogens:
- Fragmentation for protection
- Decentralization for resilience
- Reconstruction only under strict conditions
- Governance based on data sovereignty
- Scalability for diverse genomic assets
A New Category: Biosecurity for Genomic Data
Genomic information introduces new kinds of risks. GeneLock treats DNA as a strategic biological asset requiring specialized protection, aiming to establish a new category of 'biosecurity for genomic data'.
Michel Mommejat, Representative Director of Genesis Healthcare, stated: 'Genomic data is becoming the foundational infrastructure that supports healthcare, research, and the expanding bioeconomy. Through GeneLock, we aim to pioneer a new category of biosecurity for genomic assets.'
GeneLock is designed for broad use, ranging from government-led genomic programs, large-scale databases, research institutions, and life science companies, to consumer applications including select GeneLife test kits, extending advanced genetic data protection from the institutional level to the individual level. GeneLock embodies Genesis Healthcare's vision for a trusted platform for next-generation genomic biosecurity.
For more details, please visit: www.adam-innovations.com
Media Contact:
Email: press@adam-innnovations.com
About Genesis Healthcare Co., Ltd.:
Genesis Healthcare Co., Ltd. (English company name: A.D.A.M. Innovations Co.) is a pioneer in genomics, AI, and precision health solutions. It develops cutting-edge technologies across various genetic fields, including clinical diagnostics, AI-driven R&D data platforms, and consumer genetic testing services. To date, it has conducted over 2.9 million genetic tests and holds one of the largest R&D genomic databases of the Japanese population.
About GeneLock™
GeneLock™ is a secure, sovereign infrastructure for large-scale genomic data. Through encryption, fragmentation, and decentralized architecture, it enables controlled access, robust protection, and governed utilization of high-value datasets in clinical, research, and consumer domains. Designed with data sovereignty in mind, it supports deployment in on-premises and hybrid cloud environments.
GeneLock (trademark pending), GeneLife, and DNA DAY are registered trademarks of Genesis Healthcare Co., Ltd.